Moreover, within the MDA-MB-231/PRLR untreated group only one mouse showed tumor growth that reached a maximum volume of 0.875 mm3 suggesting that mouse PRL while it is described as a weak agonist of the hPRLR, it is sufficient to induce activation of the overexpressed hPRLR. Here, PRL is linked to neoplasm.